PIK3R3: A Promising Drug Target and Biomarker for Treatment of various neurological diseases

Target Name: PIK3R3

NCBI ID: G8503

PIK3R3

Other Name(s): Phosphatidylinositol 3-kinase regulatory subunit gamma | Phosphatidylinositol 3-kinase regulatory gamma subunit | PIK3R3 variant 5 | p55 | p55-GAMMA | PtdIns-3-kinase regulatory subunit gamma | PI3-kinase regulatory subunit gamma | Phosphoinositide-3-kinase regulatory subunit 3, transcript variant 1 | Phosphoinositide-3-kinase regulatory subunit 3, transcript variant 5 | PI3K regulatory subunit gamma | phosphoinositide-3-kinase regulatory subunit 3 | Phosphatidylinositol 3-kinase regulatory subunit gamma (isoform 1) | P55G_HUMAN | Phosphatidylinositol 3-kinase regulatory subunit gamma (isoform 4) | PtdIns-3-kinase regulatory subunit p55-gamma | phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 3 (p55, gamma) | PI3-kinase subunit p55-gamma | Phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 3 (p55, gamma) | p55PIK | phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma | PIK3R3 variant 1 | Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | Phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | ptdIns-3-kinase regulatory subunit p55-gamma

PIK3R3: A Promising Drug Target and Biomarker for Treatment of various neurological diseases

Introduction

Phosphatidylinositol (PI) 3-kinase (PI3K) is a protein that plays a crucial role in cellular signaling, particularly in the regulation of cell survival and growth. The PI3K signaling pathway has been implicated in various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. PIK3R3, a phosphatidylinositol 3-kinase regulatory subunit gamma, has emerged as a promising drug target and biomarker for the treatment of these disorders.

PI3K signaling pathway

The PI3K signaling pathway is a complex intracellular signaling pathway that involves the interaction of various protein factors. The pathway starts with the recruitment of the protein kinase A (PKA) to the PI3K enzyme, which activates the downstream targets, including the transcription factor CREB2 and the protein p100纬. Activated PKA then phosphates various cellular components, leading to the formation of second messenger (SM) organelles, including inositol, which activates various downstream targets.

PI3K signaling is involved in various cellular processes, including cell survival, cell growth, and cell-cell adhesion. It has been implicated in the regulation of various cellular processes, including cell proliferation, differentiation, migration, and survival. The PI3K signaling pathway is Also involved in the regulation of various signaling pathways, including the TGF-β pathway, the Wnt pathway, and the Hedgehog pathway.

Mutations in the PI3K gene have been implicated in various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. These mutations have been shown to affect the stability and activity of the PI3K enzyme, leading to the dysregulation of the PI3K signaling pathway.

PI3R3 as a drug target

The PI3K signaling pathway has been identified as a potential drug target for the treatment of various neurological and psychiatric disorders. The development of PIK3R3 inhibitors has been shown to be effective in animal models of these disorders.

One of the reasons for the effectiveness of PIK3R3 inhibitors is their ability to selectively inhibit the activity of the PI3K enzyme, without affecting the activity of other protein factors in the pathway. This selective inhibition allows for the targeting of specific downstream targets, such as PKA and p100纬, which are involved in the regulation of cellular processes that are affected by the PI3K pathway.

In addition, PIK3R3 inhibitors have been shown to have a beneficial effect on various cellular processes, including the regulation of neurotransmitter release, cell survival, and cell growth. This beneficial effect is due to the ability of these inhibitors to restore the stability and activity of the PI3K enzyme, leading to the regulation of downstream targets.

PI3R3 as a biomarker

PI3R3 has also been shown to be a potential biomarker for the diagnosis and progression of various neurological and psychiatric disorders. The PI3K signaling pathway has been implicated in the regulation of various cellular processes that are affected by these disorders, including neurotransmitter release, cell survival, and cell growth.

The dysregulation of the PI3K signaling pathway has been observed in various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. The levels of PI3K have been shown to be altered in the brains of individuals with these disorders, and the activity of the PI3K enzyme has been shown to be affected.

In addition, the levels of PI3K have been shown to be correlated with the severity of these disorders. For

Protein Name: Phosphoinositide-3-kinase Regulatory Subunit 3

Functions: Binds to activated (phosphorylated) protein-tyrosine kinases through its SH2 domain and regulates their kinase activity. During insulin stimulation, it also binds to IRS-1

The "PIK3R3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIK3R3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets